Trial
NCT04789408
Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Kite, A Gilead Company
Collaborators
—
Condition
Acute Myeloid Leukemia
Intervention
Cyclophosphamide
Why stopped
Study was terminated due to futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-11